Skip to main content
. 2020 Apr 7;11(14):1218–1234. doi: 10.18632/oncotarget.27529

Table 6B. Change in median Ki-67 (primary outcome variable) from baseline to post-intervention by race (CM only).

Variable ARM of study N Median (Min/Max) p value*
Median% Ki67 change Placebo 9 1.0 (0.0/6.0) 0.1086
Soy isoflavone 9 1.0 (0.0/2.0)

*Wilcoxon rank-sum test.